Decreased islet amyloid polypeptide staining in the islets of insulinoma patients

References

• Kahn SE, D’Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Gj T Jr, D P Jr. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes. 1990;39(5):634–8. doi:10.2337/diab.39.5.634.
   PubMed Web of Science ®Google Scholar
• Cooper GJ. IAPP compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994;15(2):163–201. doi:10.1210/edrv-15-2-163.
   PubMed Web of Science ®Google Scholar
• Young AA. Brainstem sensing of meal-related signals in energy homeostasis. Neuropharmacology. 2012;63(1):31–45. doi:10.1016/j.neuropharm.2012.03.019.
   PubMed Web of Science ®Google Scholar
• Lutz TA. The interaction of IAPP with other hormones in the control of eating. Diabetes Obes Metab. 2013;15(2):99–111. doi:10.1111/j.1463-1326.2012.01670.x.
   PubMed Web of Science ®Google Scholar
• Ludvik B, Lell B, Hartter E, Schnack C, Prager R. Decrease of stimulated IAPP release precedes impairment of insulin secretion in type II diabetes. Diabetes. 1991;40(12):1615–1619. doi:10.2337/diab.40.12.1615.
   PubMed Web of Science ®Google Scholar
• Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;15(1):97–102. doi:10.1016/0168-8227(92)90074-2.
   PubMed Web of Science ®Google Scholar
• Dimsdale JE, Kolterman O, Koda J, Nelesen R. Effect of race and hypertension on plasma IAPP concentrations. Hypertension. 1996;27(6):1273–1276. doi:10.1161/01.hyp.27.6.1273.
   PubMed Web of Science ®Google Scholar
• Kailasam MT, Parmer RJ, Tyrell EA, Henry RR, O’Connor DT. Circulating IAPP in human essential hypertension: heritability and early increase in individuals at genetic risk. J Hypertens. 2000;18(11):1611–1620. doi:10.1097/00004872-200018110-00012.
   PubMed Web of Science ®Google Scholar
• Watschinger B, Hartter E, Traindl O, Pohanka E, Pidlich J, Kovarik J. Increased levels of plasma amylin in advanced renal failure. Clin Nephrol. 1992;37(3):131–134. PMID: 1563116.
   PubMed Web of Science ®Google Scholar
• Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. J Clin Invest. 1994;94(5):2045–2050. doi:10.1172/JCI117558.
   PubMed Web of Science ®Google Scholar
• Inoue K, Hisatomi A, Umeda F, Nawata H. Release of IAPP from perfused rat pancreas in response to glucose and glucagon. Diabetes Res Clin Pract. 1992;15(1):85–88. doi:10.1016/0168-8227(92)90072-y.
   PubMed Web of Science ®Google Scholar
• Stridsberg M, Sandler S, Wilander E. Cosecretion of islet amylid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of β-cell function. Regul Pept. 1993;45(3):363–370. doi:10.1016/0167-0115(93)90362-c.
   PubMedGoogle Scholar
• Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, Ludvik B. IAPP release during oral glucose tolerance test. Diabet Med. 1997(14)Suppl2:S29–34. doi:10.1002/(sici)1096-9136(199706)14:2+3.3.co;2-s.
   Google Scholar
• Larsson H, Ahrén B. Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans. Pancreas. 1995;11(2):201–205. doi:10.1097/00006676-199508000-00015.
   PubMed Web of Science ®Google Scholar
• Qi D, Cai K, Wang O, Li Z, Chen J, Deng B, Qian L, Le Y. Fatty acids induce amylin expression and secretion by pancreatic β-cells. Am J Physiol Endocrinol Metab. 2010;298(1):E99–E107. doi:10.1152/ajpendo.00242.2009.
   PubMed Web of Science ®Google Scholar
• O’Brien TD, Westermark P, Johnson KH. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes. 1991;40(12):1701–1706. doi:10.2337/diab.40.12.1701.
   PubMed Web of Science ®Google Scholar
• Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R. Basal and stimulated plasma levels of pancreatic IAPP indicate its co-secretion with insulin in humans. Diabetologia. 1991;34(1):52–54. doi:10.1007/BF00404025.
   PubMed Web of Science ®Google Scholar
• Hieronymus L, Griffin S. Role of IAPP in type 1 and type 2 diabetes. Diabetes Educ. 2015;41(1_suppl):47S–56S. doi:10.1177/0145721715607642.
   PubMedGoogle Scholar
• Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun. 1986;140(3):827–831. doi:10.1016/0006-291x(86)90708-4.
   PubMed Web of Science ®Google Scholar
• Tomita T. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors. Islets. 2011;3(6):344–351. doi:10.4161/isl.3.6.17866.
   PubMed Web of Science ®Google Scholar
• Sho H, Fukui K, Yoneda S, Toyoda S, Ozawa H, Ishibashi C, Fujita Y, Eguchi H, Kozawa J, Shimomura I. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells. Biochem Biophys Res Commun. 2021;534:702–706. doi:10.1016/j.bbrc.2020.11.014.
   PubMed Web of Science ®Google Scholar
• Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Investig. 2012;3(1):39–40. doi:10.1111/j.2040-1124.2012.00207.x.
   PubMed Web of Science ®Google Scholar
• Bischof MG, Ludwig C, Hofer A, Kletter K, Krebs M, Stingl H, Nowotny P, Waldhäusl W, Roden M. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2. Horm Metab Res. 2000;32(10):417–423. doi:10.1055/s-2007-978664.
   PubMed Web of Science ®Google Scholar
• Sprague JE, Arbeláez AM. Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev. 2011;9(1):463–473.
   PubMedGoogle Scholar
• Gedulin BR, Young AA. Hypoglycemia overrides IAPP-mediated regulation of gastric emptying in rats. Diabetes. 1998;47(1):93–97. doi:10.2337/diab.47.1.93.
   PubMed Web of Science ®Google Scholar
• Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, Matsuo H, Matsukura S. Islet amyloid polypeptide response to glucose, Insulin, and somatostatin analogue administration. Diabetes. 1990;39(5):639–642. doi:10.2337/diab.39.5.639.
   PubMed Web of Science ®Google Scholar
• Honegger M, Lutz TA, Boyle CN. Hypoglycemia attenuates acute IAPP-induced reduction of food intake in male rats. Physiol Behav. 2021;237:113435. doi:10.1016/j.physbeh.2021.113435.
   PubMed Web of Science ®Google Scholar
• Alam T, Chen L, Ogawa A, Leffert JD, Unger RH, Luskey KL. Coordinate regulation of IAPP and insulin expression in response to hypoglycemia and fasting. Diabetes. 1992;41(4):508–514. doi:10.2337/diab.41.4.508.
   PubMed Web of Science ®Google Scholar
• Coll AP, Farooqi IS, O’Rahilly S. The hormonal control of food intake. Cell. 2007;129(2):251–262. doi:10.1016/j.cell.2007.04.001.
   PubMed Web of Science ®Google Scholar
• Moran TH. Gut peptides in the control of food intake. Int J Obes (Lond). 2009;33(1):S7–10. doi:10.1038/ijo.2009.9.
   PubMed Web of Science ®Google Scholar
• Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther. 2009;124(1):44–56. doi:10.1016/j.pharmthera.2009.06.005.
   PubMed Web of Science ®Google Scholar